Last reviewed · How we verify

NCT04073355

Smart Walk 50+: Feasibility of a Smartphone-delivered Physical Activity Program for African American Women 50 Years and Older

Completed NA Last updated 8 July 2020
What this trial tests

NA trial testing Physical Activity in Physical Activity in 20 participants. Completed in 30 June 2020.

Timeline
10 August 2019
Primary endpoint
30 June 2020
30 June 2020

Quick facts

Lead sponsorArizona State University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment20
Start date10 August 2019
Primary completion30 June 2020
Estimated completion30 June 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Arizona State University

Who can join

Adults 50 to 65, female only, with Physical Activity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to establish the acceptability and feasibility of a culturally relevant, theory-based smartphone-delivered physical activity intervention among African American women aged 50-65 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Results of a Culturally Tailored Smartphone-Delivered Physical Activity Intervention Among Midlife African American Women: Feasibility Trial.
    Joseph RP, Ainsworth BE, Hollingshead K, Todd M, et al · · 2021 · cited 24× · PMID 33885368 · DOI 10.2196/27383

Verify or expand the search:

Other trials of Physical Activity

Trials testing the same drug.

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other Arizona State University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04073355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing